CDKN1A and cancer: Compared with cisplatin alone, the combination of cisplatin with EGCG increased the expression of P19, P53, and P21 at both mRNA and protein levels, leading to cell cycle arrest in G1 phase and promoting apoptosis of cancer cells (157).